Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer (Q86521367)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122232 AND SRC:MED&resulttype=core&format=json

27 February 2020

title

Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122232 AND SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

non-small-cell lung carcinoma

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122232 AND SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Cong Zhang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122232 AND SRC:MED&resulttype=core&format=json

27 February 2020

Leiguang Ye

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122232 AND SRC:MED&resulttype=core&format=json

27 February 2020

Songlei Guan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122232 AND SRC:MED&resulttype=core&format=json

27 February 2020

Shunzi Jin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122232 AND SRC:MED&resulttype=core&format=json

27 February 2020

Shilong Sun

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122232 AND SRC:MED&resulttype=core&format=json

27 February 2020

Kuang-Hui Lee

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122232 AND SRC:MED&resulttype=core&format=json

27 February 2020

Jun Wei

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122232 AND SRC:MED&resulttype=core&format=json

27 February 2020

Baogang Liu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122232 AND SRC:MED&resulttype=core&format=json

27 February 2020

publication date

1 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122232 AND SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122232 AND SRC:MED&resulttype=core&format=json

27 February 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122232 AND SRC:MED&resulttype=core&format=json

27 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122232 AND SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

2047-2051

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24122232 AND SRC:MED&resulttype=core&format=json

Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma

27 February 2020

cites work

1 reference

12 December 2020

A systematic review of humoral immune responses against tumor antigens

1 reference

12 December 2020

The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis

1 reference

12 December 2020

Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins

1 reference

12 December 2020

Profiling tumor-associated antibodies for early detection of non-small cell lung cancer

1 reference

12 December 2020

Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia

1 reference

12 December 2020

Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?

1 reference

12 December 2020

Autoantibodies against tumor-related antigens: incidence and biologic significance

1 reference

12 December 2020

Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies.

1 reference

12 December 2020

Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins

1 reference

12 December 2020

Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer

1 reference

12 December 2020

Altered p16(INK4) and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung Cancer

1 reference

12 December 2020

Autoantibodies in breast cancer: their use as an aid to early diagnosis

1 reference

12 December 2020

Tumor suppressors and cell-cycle proteins in lung cancer

1 reference

12 December 2020

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1 reference

12 December 2020

EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays

1 reference

12 December 2020

Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis

1 reference

12 December 2020

Autoantibodies in cancer: prognostic biomarkers and immune activation

1 reference

12 December 2020

Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer

1 reference

12 December 2020

Genetic and biochemical alterations in non-small cell lung cancer

1 reference

12 December 2020

Concept and application of a computational vaccinology workflow

1 reference

12 December 2020

Peptide binding predictions for HLA DR, DP and DQ molecules

1 reference

12 December 2020

EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer

1 reference

12 December 2020

Expression of p16 in non-small cell lung cancer and its prognostic significance: A meta-analysis of published literatures

1 reference

12 December 2020